Ivan D. Horak
2008
In 2008, Ivan D. Horak earned a total compensation of $1.4M as Former President, Research and Development and Chief Scientific Officer at Enzon Pharmaceuticals, a 23% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $320,000 |
|---|---|
| Salary | $532,857 |
| Stock Awards | $512,600 |
| Other | $38,872 |
| Total | $1,404,329 |
Horak received $532.9K in salary, accounting for 38% of the total pay in 2008.
Horak also received $320K in non-equity incentive plan, $512.6K in stock awards and $38.9K in other compensation.
Rankings
In 2008, Ivan D. Horak's compensation ranked 3,389th out of 9,135 executives tracked by ExecPay. In other words, Horak earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,389 out of 9,135 | 63rd |
Division Manufacturing | 1,211 out of 3,436 | 65th |
Major group Chemicals And Allied Products | 228 out of 815 | 72nd |
Industry group Drugs | 129 out of 597 | 78th |
Industry Biological Products, Except Diagnostic Substances | 22 out of 118 | 81st |
Source: SEC filing on April 8, 2011.
Horak's colleagues
We found five more compensation records of executives who worked with Ivan D. Horak at Enzon Pharmaceuticals in 2008.
2008
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2008
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2008
Ralph del Campo
Enzon Pharmaceuticals
Chief Operating Officer
2008
Paul Davit
Enzon Pharmaceuticals
Executive Vice President, Human Resources and Administration
2008
Mark Ogden
Enzon Pharmaceuticals